Nuclear Medicine

  • Radioimmunoscintigraphy (monoclonal antibody imaging) with In-111 capromab pendetide (Prostascint®) for evaluation of patients with prostate cancer.
  • Positron emission tomography (PET) with F-18 fluorodeoxyglucose (FDG) for imaging of tumors in patients with cancer
    PET with FDG, as well as single-photon emission computed tomography (SPECT) with Tc-99m bicisate (Neurolite®) for imaging of patients with epilepsy in whom treatment by surgery is being considered.
  • Imaging with I-123 iobenguane (MIBG) and In-111 pentetreotide (Octreoscan®) for detection of various types of neuroendocrine tumors (pheochromocytomas, neuroblastomas, pancreatic islet cell tumors, carcinoid tumors).
  • Sentinel lymph node mapping in patients with malignant melanoma and breast cancer.
  • Brain SPECT with I-123 ioflupane (DaTscan) for evaluation of patients with suspected parkinsonian syndromes.
  • Amyvid (florbetapir) PET imaging for detection of amyloid plaque in Alzheimer's disease.
  • F-18 Fluoride PET bone scintigraphy, for high resolution bone imaging.